BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11387614)

  • 1. Late stent thrombosis without antecedent brachytherapy: confirmation and treatment with rheolytic thrombectomy.
    Kalaria VG; Ling FS
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):243-7. PubMed ID: 11387614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.
    Teirstein P; Reilly JP
    J Invasive Cardiol; 2002 Mar; 14(3):109-14. PubMed ID: 11870263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis.
    Rinfret S; Cutlip DE; Katsiyiannis PT; Ho KK; Cohen DJ; Carrozza JP; Laham RJ
    Catheter Cardiovasc Interv; 2002 Sep; 57(1):24-30. PubMed ID: 12203922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheolytic thrombectomy: a new treatment for stent thrombosis.
    Scott LR; Silva JA; White C; Collins TJ
    Catheter Cardiovasc Interv; 1999 May; 47(1):97-101. PubMed ID: 10385170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheolytic thrombectomy for in-stent thrombosis: creating a diagnostic window.
    Adams MR; Blake GJ; Kinlay S; Rogers C
    J Interv Cardiol; 2001 Feb; 14(1):27-31. PubMed ID: 12053323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy.
    Zavalloni D; Rossi M; Belli G; Scatturin M; Morenghi E; Marsico F; Catalano G; Tosi G; Pagnotta P; Presbitero P
    J Invasive Cardiol; 2005 Nov; 17(11):598-602. PubMed ID: 16264205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
    Park DW; Park SW; Park KH; Lee BK; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2006 Aug; 98(3):352-6. PubMed ID: 16860022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent very late drug-eluting stent thrombosis.
    Pesarini G; Arieti M; Spadaro R; Vassanelli C; Ribichini F
    Cardiovasc Revasc Med; 2009; 10(2):130-5. PubMed ID: 19327678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Edge effect and late thrombosis -- inevitable complications of vascular brachytherapy?].
    Schiele TM; Staber L; Kantlehner R; Pöllinger B; Dühmke E; Theisen K; Klauss V
    Z Kardiol; 2002 Nov; 91(11):869-78. PubMed ID: 12442189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very late stent thrombosis in a bare-metal stent, 9 years after implantation.
    Almasswary AA
    Saudi Med J; 2009 Jun; 30(6):847-50. PubMed ID: 19526174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention, treatment, and secondary prevention of late and very late stent thrombosis.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S27-33. PubMed ID: 17401308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcutaneous rheolytic thrombectomy in combination with stenting of distal anastomosis in thrombosis of femoro-popliteal bypass].
    Kondrashin SA; Shcherbiuk AN; Frolov KB; Stoĭda AIu; Zaĭtsev AIu; Smirnov VE; Artiukhina EG; Ul'ianov D DA
    Khirurgiia (Mosk); 2001; (10):53-5. PubMed ID: 11763823
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting.
    Brichon PY; Boitet P; Dujon A; Mouroux J; Peillon C; Riquet M; Velly JF; Ris HB
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):793-6. PubMed ID: 16996274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedural efficacy and complications of X-Sizer thrombectomy in de novo and stented lesions.
    Pate GE; Lowe R; Kuchela A; Buller CE; Vaderah S; Carere RG; Ricci DR; Hamburger JN; Webb JG
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):177-82; discussion 183. PubMed ID: 15390253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years.
    Ellis SG; Colombo A; Grube E; Popma J; Koglin J; Dawkins KD; Stone GW
    J Am Coll Cardiol; 2007 Mar; 49(10):1043-51. PubMed ID: 17349883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of AngioJet mechanical thrombectomy for acute peripheral ischemia associated with stent fracture.
    Barbato JE; Wholey MH
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):795-8. PubMed ID: 18022849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of coronary aneurysm in acute myocardial infarction with AngioJet thrombectomy and JoStent coronary stent graft.
    Lee MS; Nero T; Makkar RR; Wilentz JR
    J Invasive Cardiol; 2004 May; 16(5):294-6. PubMed ID: 15152122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment.
    Airoldi F; Colombo A; Morici N; Latib A; Cosgrave J; Buellesfeld L; Bonizzoni E; Carlino M; Gerckens U; Godino C; Melzi G; Michev I; Montorfano M; Sangiorgi GM; Qasim A; Chieffo A; Briguori C; Grube E
    Circulation; 2007 Aug; 116(7):745-54. PubMed ID: 17664375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.